| # | Drug | Count |
|---|---|---|
| 0 | PEGFILGRASTIM | 11933 |
| 1 | ESTRADIOL | 1410 |
| 2 | ESTRADIOL GEL 0.1% | 1249 |
| 3 | ESTRADIOL TRANSDERMAL | 1249 |
| 4 | ESTRADIOL, | 1249 |
| 5 | FENTANYL | 405 |
| 6 | ROTIGOTINE | 377 |
| 7 | METHYLPHENIDATE | 304 |
| 8 | ESTRADIOL AND LEVONORGESTREL | 268 |
| 9 | TREPROSTINIL | 135 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 11933 | 0.9962 |
| 1 | ESTRADIOL AND LEVONORGESTREL | 268 | 0.1300 |
| 2 | ESTRADIOL TRANSDERMAL | 1249 | 0.0266 |
| 3 | ROTIGOTINE | 377 | 0.0256 |
| 4 | ESTRADIOL | 1410 | 0.0163 |
| 5 | 70% ISOPROPY ALCOHOL SWAB | 1 | 0.0130 |
| 6 | KETAMINE HYDROCHLORIDE | 26 | 0.0051 |
| 7 | PEGFILGRASTIM-CBQV | 7 | 0.0049 |
| 8 | NORELGESTROMIN AND ETHINYL ESTRADIOL | 9 | 0.0048 |
| 9 | FENTANYL | 405 | 0.0041 |
| # | Drug class | Count |
|---|---|---|
| 0 | Leukocyte Growth Factor [EPC] | 11940 |
| 1 | Estrogen [EPC] | 1691 |
| 2 | Opioid Agonist [EPC] | 413 |
| 3 | Nonergot Dopamine Agonist [EPC] | 379 |
| 4 | Central Nervous System Stimulant [EPC] | 308 |
| 5 | Progestin [EPC] | 291 |
| 6 | Progestin-containing Intrauterine System [EPC] | 270 |
| 7 | Prostacycline Vasodilator [EPC] | 135 |
| 8 | Endothelin Receptor Antagonist [EPC] | 91 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 64 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leukocyte Growth Factor [EPC] | 11940 | 0.0836 |
| 1 | Nonergot Dopamine Agonist [EPC] | 379 | 0.0243 |
| 2 | Estrogen [EPC] | 1691 | 0.0090 |
| 3 | Central Nervous System Stimulant [EPC] | 308 | 0.0035 |
| 4 | Progesterone [EPC] | 58 | 0.0024 |
| 5 | Opioid Agonist [EPC] | 413 | 0.0015 |
| 6 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 7 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 8 | Provitamin D2 Compound [EPC] | 30 | 0.0010 |
| 9 | Progestin [EPC] | 291 | 0.0010 |